DOSSIER · 13F-HR · Q1 2026

Tao Capital Management LP

$119M in tracked AUM across 8 positions as of Q1 2026.

TC
CIK 0001802967 · last filed Mar 31, 2026
Total AUM
$119M
as of Q1 2026
Holdings
8
positions
Whale Score
69
69
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

Based on the SEC 13F filing for Tao Capital Management LP for the period ending September 30, 2025, here is a comprehensive financial analysis.

1. Portfolio Overview

Tao Capital Management LP manages a highly concentrated portfolio valued at approximately $103.46 million, representing a significant decrease of 24.1% from the previous quarter's $136.37 million. This reduction in value is attributable to a combination of asset reallocation and potential market depreciation in existing hol...

2. Key Holdings

The portfolio is dominated by three major positions, each representing a significant bet on specific sectors:

  • Tesla, Inc. (TSLA): As the largest holding, TSLA comprises 37.07% of the portfolio ($38.36 million). Despite the reduction in overall portfolio value, the share count remained unchanged at 86,000 shares, suggesting the firm maintained its conviction in the consumer cyclical giant throughout the quarter.
  • Ouster, Inc. (OUST): Ouster is the second-largest holding, representing 29.42% of the portfolio ($30.44 million). With 1.13 million shares held, this technology stock indicates a strong focus on the lidar and autonomous driving sector. The stability of the share count (1 of 7 unchanged positions) suggests no profit-taking or accumulation occurred despite market fluctuations.
  • Twist Bioscience Corporation (TWST): This healthcare position occupies 22.54% of the portfolio ($23.32 million). With 829,000 shares, Tao Capital maintains a substantial stake in the synthetic biology and genomics space.

3. Sector Allocation

The portfolio displays a distinct sector tilt with little regard for traditional defensive diversification.

  • Consumer Cyclical (37.07%): Entirely represented by Tesla, this sector provides the portfolio's largest exposure.
  • Technology (29.42%): Driven primarily by Ouster, this allocation highlights a focus on innovative hardware and sensing technologies.
  • Healthcare (29.50%): This sector is surprisingly well-represented relative to the portfolio size, driven by Twist Bioscience (22.54%), Warby Parker (3.58%), and the new position in 10x Genomics (2.38%).
  • Unknown (5.00%): A small portion of the portfolio is allocated to holdings not clearly categorized in the standard sectors (908 Devices, Sonder Holdings, and Ginkgo Bioworks).

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
TWST
Twist Bioscience Corporation
$39M829K33.1%
02
TSLA
Tesla, Inc.
$32M86K27.0%
03
OUST
Ouster, Inc.
$16M845K13.1%
04
MDGL
Madrigal Pharmaceuticals, Inc.
$11M21K9.3%
05
H
Hyatt Hotels Corporation
$10M70K8.5%
06
TXG
10x Genomics, Inc.
$4M211K3.8%
07
MASS
908 Devices Inc.
$3M569K2.9%
08
WRBY
Warby Parker Inc.
$3M134K2.4%

Filing history

2026Q1Mar 31
$119M 2.3%
8 positionsView →
2025Q4Dec 31
$116M 12.3%
8 positionsView →
2025Q3Sep 30
$103M 24.1%
8 positionsView →
2025Q2Jun 30
$136M 94.3%
9 positionsLocked
2025Q1Mar 31
$70M 51.0%
7 positionsLocked
2024Q4Dec 31
$143M 29.8%
10 positionsLocked
2024Q3Sep 30
$110M 9.5%
10 positionsLocked
2024Q2Jun 30
$122M 15.6%
10 positionsLocked
2024Q1Mar 31
$106M 3.4%
10 positionsLocked
2023Q4Dec 31
$109M 15.3%
12 positionsLocked
2023Q3Sep 30
$129M 5.4%
11 positionsLocked
2023Q2Jun 30
$137M 8.6%
14 positionsLocked
Showing 12 of 26